BIOMAT Database Logo BIOMAT Database Logo

Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1. 2003

Santiago Moreno, and José L Casado, and María J Pérez-Elías, and Fernando Dronda, and Antonio Antela, and Ana Moreno, and Carolina Gutiérrez

UI MeSH Term Description Entries
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D048588 Benzoxazines OXAZINES with a fused BENZENE ring. Benzoxazine,Benzoxazinoid,Benzoxazinone,Benzoxazinones,Benzoxazinoids
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019829 Nevirapine A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS. BI-RG-587,Nevirapine Hemihydrate,Viramune,BI RG 587,BIRG587,Hemihydrate, Nevirapine
D020008 Delavirdine A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. Delavirdine Mesylate,Rescriptor,U-90152,U-90152S,Mesylate, Delavirdine,U 90152,U 90152S,U90152,U90152S

Related Publications

Santiago Moreno, and José L Casado, and María J Pérez-Elías, and Fernando Dronda, and Antonio Antela, and Ana Moreno, and Carolina Gutiérrez
Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors.
April 2006, AIDS (London, England),
Santiago Moreno, and José L Casado, and María J Pérez-Elías, and Fernando Dronda, and Antonio Antela, and Ana Moreno, and Carolina Gutiérrez
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates.
October 2002, AIDS (London, England),
Santiago Moreno, and José L Casado, and María J Pérez-Elías, and Fernando Dronda, and Antonio Antela, and Ana Moreno, and Carolina Gutiérrez
Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase.
February 1999, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy,
Santiago Moreno, and José L Casado, and María J Pérez-Elías, and Fernando Dronda, and Antonio Antela, and Ana Moreno, and Carolina Gutiérrez
Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors.
February 2006, Current opinion in investigational drugs (London, England : 2000),
Santiago Moreno, and José L Casado, and María J Pérez-Elías, and Fernando Dronda, and Antonio Antela, and Ana Moreno, and Carolina Gutiérrez
Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors.
December 2013, Future medicinal chemistry,
Santiago Moreno, and José L Casado, and María J Pérez-Elías, and Fernando Dronda, and Antonio Antela, and Ana Moreno, and Carolina Gutiérrez
[HIV resistance to non-nucleoside reverse transcriptase inhibitors].
August 2006, Virologie (Montrouge, France),
Santiago Moreno, and José L Casado, and María J Pérez-Elías, and Fernando Dronda, and Antonio Antela, and Ana Moreno, and Carolina Gutiérrez
QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase.
September 2006, Bioorganic & medicinal chemistry,
Santiago Moreno, and José L Casado, and María J Pérez-Elías, and Fernando Dronda, and Antonio Antela, and Ana Moreno, and Carolina Gutiérrez
[Mechanisms of HIV-1 drug resistance to nucleoside and non-nucleoside reverse transcriptase inhibitors].
January 2011, Molekuliarnaia biologiia,
Santiago Moreno, and José L Casado, and María J Pérez-Elías, and Fernando Dronda, and Antonio Antela, and Ana Moreno, and Carolina Gutiérrez
Mass Spectrometric Characterization of HIV-1 Reverse Transcriptase Interactions with Non-nucleoside Reverse Transcriptase Inhibitors.
January 2016, Biological & pharmaceutical bulletin,
Santiago Moreno, and José L Casado, and María J Pérez-Elías, and Fernando Dronda, and Antonio Antela, and Ana Moreno, and Carolina Gutiérrez
HIV nucleoside reverse transcriptase inhibitors.
October 2022, European journal of medicinal chemistry,
Copied contents to your clipboard!